Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
2008 - Ambuja Cements Ltd has appointed Mr. Naresh Chandra as an additional director. 2009 - The Company launched its knowledge initiative i.e. Ambuja Knowledge Center,to enable industry professionals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results